BluePath Options, on behalf of Johnson & Johnson Modern Drugs, is conducting an internet research to assemble info that would assist enhance therapy satisfaction and empower sufferers to take part actively of their therapy choice.
The aim of this research is to judge what elements are essential to sufferers when contemplating oral medicine(s) for pulmonary arterial hypertension (PAH).
Members will probably be requested to finish a 30-minute on-line survey wherein they’ll reply questions on their demographic / illness traits, present their opinions about oral PAH therapies, and point out their choice for hypothetical oral PAH therapies.
All responses will probably be saved nameless, and contributors will probably be compensated $50 for his or her time.
The next respondents are eligible to take part:
Adults 18+ years.
Capable of communicate, learn and perceive English.
Recognized with PAH (WHO Group 1).
Used an oral PAH medicine for 3+ months throughout the previous yr.
Please navigate to the research net web page in case you are concerned about taking part.